Brain Microglia and Microglial Markers

Neuroscience and Behavioral Physiology

Volumn 46, Issue 3, 2016, Pages 284-290

  Korzhevskii, D E ^a   Kirik, O V ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

brain; CD11b; CD68; Iba 1; immunocytochemistry; microglia; OX 42

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; BIOLOGICAL MARKER; CD11B ANTIGEN; CD68 ANTIGEN; HLA DR ANTIGEN; LYMPHOCYTE ANTIGEN; PROTEIN ED2; UNCLASSIFIED DRUG;

ARTICLE; BRAIN CELL; HUMAN; IMMUNOCYTOCHEMISTRY; MICROGLIA; NONHUMAN; PROTEIN EXPRESSION;

EID: 84955290841     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-016-0231-z     Document Type: Article

References (73)

1. V. K. Beletskii, A Method for Microscopic Studies of the Nervous System, Krest’yanskaya Gazeta, Moscow (1939).
2. V. K. Beletskii, “Neurology in health and disease,” in: A Handbook of Pathological Anatomy in Several Volumes, Medical Literature Press, Moscow (1963), Vol. II, pp. 55–82.
3. P. N. Ermokhin, Histopathology of the Central Nervous System: An Atlas of Photomicrographs, Meditsina, Moscow (1969).
4. O. V. Kirik, O. S. Alekseeva, A. N. Moskvin, and D. E. Korzhevskii, “Effects of hyperbaric oxygenation on the state of the subependymal microglia of the brain in rats,” Zh. Evolyuts. Biokhim., 50, No. 4, 312–314 (2014).
5. O. V. Kirik, E. G. Sukhorukova, O. S. Alekseeva, and D. E. Korzhevskii, “Subependymal microgliocytes of the III ventricle of the brain,” Morfologiya, 145, No. 3, 67–69 (2014).
6. O. V. Kirik, E. G. Sukhorukova, and D. E. Korzhevskii, “Calciumbinding protein Iba-1/AIF-1 in brain cells in the rat,” Morfologiya, 137, No. 2, 5–8 (2010).
7. D. E. Korzhevskii, “The tissue organization and development of the vascular plexus of the brain in humans,” Morfologiya, 113, No. 2, 105–114 (1998).
8. D. E. Korzhevskii, “Macrophages in the vascular plexus of the telencephalon in the human brain,” Morfologiya, 119, No. 1, 20–23 (2001).
9. D. E. Korzhevskii, O. V. Kirik, E. G. Sukhorukova, and T. D. Vlasov, “Structural organization of microgliocytes in the striatum after transient focal ischemia,” Morfologiya, 141, No. 2, 19–24 (2012).
10. D. E. Korzhevskii, O. V. Kirik, E. G. Sukhorukova, et al., “Studies of the spatial organization of astrocytes in the brain using confocal laser microscopy,” Morfologiya, 135, No. 3, 76–79 (2009).
11. D. E. Korzhevskii, O. V. Kirik, E. G. Sukhorukova, and M. A. Syrtsova, “Microglia in the substantia nigra of the brain in humans,” Med. Akad. Zh., 14, No. 4, 68–72 (2014).
12. D. E. Korzhevskii, M. V. Lentsman, O. V. Kirik, and V. A. Otellin, “Morphological types of activated microglia in the hippocampus seen after transient general cerebral ischemia,” Morfologiya, 142, No. 5, 30–33 (2012).
13. D. E. Korzhevskii, V. A. Otellin, A. A. Neokesariiskii, and N. G. Pavlova, “Structural organization of the forming human placenta,” Morfologiya, 128, No. 6, 60–62 (2005).
14. D. E. Korzhevskii, E. G. Sukhorukova E. G. Gilerovich, et al., “Advantages and disadvantages of zinc-ethanol-formaldehyde as a fixative for immunohistochemical studies and confocal laser microscopy,” Morfologiya, 143, No. 2, 81–85 (2013).
15. D. E. Korzhevskii, E. G. Sukhorukova E. G., and O. V. Kirik, “Use of immunocytochemical markers to detect activated microglia and macrophages in the brain,” in: Current Questions in Functional Interhemisphere Asymmetry and Neuroplasticity: Proc. All-Russ. Conf., Nauchnyi Mir, Moscow (2008), pp. 588–590.
16. I. V. Manzhulo, Neuroglial Interactions in the Mechanisms of Development of Pain and Therapeutic Analgesia in Rats: Auth. Abstr. Mast. Thesis in Biol. Sci., Vladivostok (2013).
17. V. A. Otellin and D. E. Korzhevskii, “Formation and structural organization of the barrier at the outer surface of the brain,” Morfologiya, 122, No. 6, 14–18 (2002).
18. E. G. Sukhorukova, M. S. Zakhryapin, N. N. Anichkov, and D. E. Korzhevskii, “Detection of microglia in brain preparations stored for prolonged periods in formalin solution,” Morfologiya, 142, No. 5, 32–35 (2012).
19. E. G. Sukhorukova, O. V. Kirik, and D. E. Korzhevskii, “Use of an immunohistochemical method to detect brain microglia in paraffin sections,” Byull. Eksperim. Biol., 149, No. 6, 709–712 (2010).
20. L. I. Khozhai and V. A. Otellin, “Reactive changes in microglia in the rat neocortex and hippocampus after exposure to acute perinatal hypoxia,” Morfologiya, 143, No. 1, 23–27 (2013).
21. F. Alliott and I. Godin, “Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain,” Brain Res. Dev. Brain Res., 117, No. 2, 145–152 (1999).
22. D. R. Beers, J. S. Henkel, Q. Xiao, et al., “Wild-type microglia extend survival in PU1 knockout mice with familial amyotrophic lateral sclerosis,” Proc. Natl. Acad. Sci. USA, 103, 16021–16026.
23. L. Benimetskaya, J. D. Loike, Z. Khaled, et al., “Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein,” Nat. Med., 3, No. 4, 414–420 (1997).
24. D. Boche, V. H. Perry, and J. A. Nicoll, “Review: activation patterns of microglia and their identification in the human brain,” Neuropathol. Appl. Neurobiol., 39, 3–18 (2013).
25. J. G. Damoiseaux, E. A. Dopp, W. Calame, et al., “Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1,” Immunology, 83, 140–147 (1994).
26. M. H. Deininger, R. Meyermann, and H. J. Schluesener, “The allograft inflammatory factor-1 family of proteins,” FEBS Lett., 514, 115–121 (2002).
27. C. D. Dijkstra, E. A. Dopp, P. Joling, and G. Kraal, “The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3,” Immunology, 54, 589–599 (1985).
28. C. D. Dijkstra, E. A. Dopp, T. K. Van der Burg, and J. G. Damoiseaux, “Monoclonal antibodies against rat macrophages,” J. Immunol. Meth., 174, 21–23 (1994).
29. S. G. Elner, V. M. Elner, J. C. Nielsen, et al., “CD68 antigen expression by human retinal pigment epithelial cells,” Exp. Eye Res., 55, No. 1, 21–28 (1992).
30. G. P. Fadini, R. Cappellari, M. Mazzucato, et al., “Monocyte-mac rophage polarization balance in pre-diabetic individuals,” Acta Diabetol., 50, No. 6, 977–982 (2013).
31. B. Falini, L. Flenghi, S. Pileri, et al., “PG-M1: a new monoclonal anti body direct against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule,” Am. J. Pathol., 142, No. 5, 1359–1372 (1993).
32. A. Flugel, M. Bradi, G. W. Kreutzberg, and M. B. Graeber, “Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy,” J. Neurosci. Res., 66, No. 1, 74–82 (2001).
33. F. Ginhoux, M. Greater, M. Leboeuf, et al., “Fate mapping analysis reveals that adult microglia derive from primitive macrophages,” Science, 330, 841–845 (2010).
34. M. B. Graeber and W. J. Streit, “Microglia: biology and pathology,” Acta Neuropathol., 119, 89–105 (2010).
35. M. Greater and M. Merad, “Regulation of microglia development and homeostasis,” Glia, 61, 121–127 (2013).
36. G. J. Harry and A. D. Kratt, “Microglia in the developing brain: a potential target with lifetime effects,” Neurotoxicology, 33, 191–206 (2012).
37. C. L. Holness and D. L. Simmons, “Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins,” Blood, 81, 1607–1613 (1993).
38. R. J. Horvath, E. A. Romero-Sandoval, and J. A. De Leo, “Inhibition of microglial P2X4 receptor attenuates morphine tolerance, Iba1, GFAP and mu opioid receptor protein expression while enhancing perivascular microglial ED2,” Pain, 150, No. 3, 401–413 (2010).
39. Y. Imai, I. Ibata, D. Ito, et al., “A novel gene Iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage,” Biochem. Biophys. Res. Commun., 224, 855–862 (1996).
40. Y. Imai and S. Kohsaka, “Intracellular signaling in M-CSF-induced microglia activation: role of Iba1,” Glia, 40, 164–174 (2002).
41. D. Ito, Y. Imai, K. Ohsawa, et al., “Microglia-specific localization of a novel calcium binding protein, Iba1,” Brain Res. Mol. Brain Res., 57, 1–9, (1998).
42. C. Kaur and E.-A. Ling, “Increased expression of transferrin receptors and iron in ameboid microglial cells in postnatal rats following an exposure to hypoxia,” Neurosci. Lett., 262, 183–186 (1999).
43. C. Kaur, G. Rathnasamy, and E.-A. Ling, “Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina,” J. Neuroim. Pharmacol., 8, 66–78 (2013).
44. K. Kawai, N. H. Tsuno, M. Matsuhashi, et al., “CD11b-mediated migratory property of peripheral blood B cell,” J. Allergy Clin. Immunol., 116, No. 1, 192–197 (2005).
45. C. Kohler, “Allograft inflammatory factor-1/Ionized calcium binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis,” Cell Tissue Res., 33, 291–302 (2007).
46. G. W. Kreutzberg, “Microglia: a sensor for pathological events in the CNS,” Trends Neurosci., 19, No. 8, 312–318 (1996).
47. R. Ladeby, M. Wirenfeldt, D. Garcia-Ovejero, et al., “Microglial cell population dynamics in the injured adult central nervous system,” Brain Res. Brain Res. Rev., 48, No. 2, 196–206 (2005).
48. E.-A. Ling, C. Kaur, and J. Lu, “Origin, nature and some functional considerations of intraventricular macrophages, with special reference to the epiplexus cells,” Microsc. Res. Tech., 41, No. 1, 235–342 (1998).
49. M. MacPherson, H. S. Lek, A. Prescott, and S. C. Fagerholm, “A systemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis,” J. Biol. Chem., 286, 17,303–17,310 (2011).
50. S. A. Marshall, J. A. McClain, M. L. Kelso, et al., “Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype,” Neurobiol. Dis., 54, 239–251 (2013).
51. S. M. McKay, D. J. Brooks, P. Hu, and E. M. McLachlan, “Distinct types of microglial activation in white and grey matter of rat lumbosacral cord after mid-thoracic spinal transection,” J. Neuropathol. Exp. Neurol., 66, 698–710 (2007).
52. T. Morioka, A. N. Kalehua, and W. J. Streit, “Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia,” Acta Neuropathol., 83, No. 2, 149–157 (1992).
53. H. P. Ng, S. C. Chiang, Y. Chi, and S. T. Lee, “Identification of macrosialin (CD68) on the surface of host macrophages as the receptor for the intercellular adhesive molecule (ICAM-L) of Leishmania amazonensis,” Int. J. Parasitol., 39, 1539–1550 (2009).
54. K. Osawa, Y. Imai, H. Kanazawa, et al., “Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia,” J. Cell Sci., 133, 3073–3084 (2000).
55. K. Osawa, Y. Imai, Y. Sasaki, and S. Kohsaka, “Microglia/macrophages-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity,” J. Neurochem., 88, 844–856 (2004).
56. G. D. Ross, “Role of the lectin domain of Mac-1/CR3 (CD11b/ CD18) in regulating intercellular adhesion,” Immunol. Res, 25, No. 3, 219–227 (2002).
57. G. D. Ross and V. Vetvicka, “CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions,” Clin. Exp. Immunol., 92, 181–184 (1993).
58. Y. Sasaki, K. Ohsawa, H. Kanazawa, et al., “Iba1 is an actin-crosslinking protein in macrophage/microglia,” Biochem. Biophys. Res. Commun., 286, 292–297 (2001).
59. A. Schuitemaker, T. F. Van der Doef, R. Boellard, et al., “Microglia activation in healthy aging,” Neurobiol. Aging, 33, 1067–1072 (2012).
60. C. M. Shikuma, L. M. Gangcuangco, D. A. Killebrew, et al., “The role of HIV and monocytes/macrophages in adipose tissue biology,” J. Acquir. Imm. Defic. Syndr., 65, No. 2, 151–159 (2014).
61. Y. J. Shin, J. M. Park, J. M. Cho, et al., “Induction of vascular endothelial growth factor receptor-3 expression in perivascular cells of the ischemic core following focal cerebral ischemia in rats,” Acta Histochem., 115, No. 2, 170–177(2013).
62. C. Smith, S. M. Gentleman, P. D. Leclerq, et al., “The inflammatory response in humans after traumatic brain injury,” Neuropathol. Appl. Neurobiol., 39, 654–666 (2013).
63. C. Sobin, M. G. Montoya, N. Parisi, et al., “Microglial disruption in young mice with early chronic lead exposure,” Toxicol. Lett., 220, 44–52 (2013).
64. L. Song, C. Lee, and C. Schindler, “Deletion of the murine scavenger receptor CD68,” J. Lipid Res., 52, 1542–1550 (2011).
65. W. J. Streit, N. W. Sammons, A. J. Kuhns, and D. L. Sparks, “Dystrophic microglia in the aging human brain,” Glia, 45, 208–212 (2004).
66. K. Suzuki, G. Sugihara, Y. Ouchi, et al., “Microglial activation in young adults with autism spectrum disorder,” JAMA Psychiatry, 70, 49–58 (2013).
67. R. Todd, “The continuing saga of complement receptor type 3 (CR3),” J. Clin. Invest., 98, No. 1, 1–2 (1996).
68. M. Tremblay, B. Stevens, A. Sierra, et al., “The role of microglia in the healthy brain,” J. Neurosci., 31, 16,064–16,069 (2011).
69. M. M. Varnum and T. Ikezu, “The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer’s disease brain,” Arch. Immunol. Ther. Exp., 60, 251–266 (2012).
70. H. Wake, A. J. Moorhouse, S. Jinno, et al., “Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals,” J. Neurosci., 29, 3974–3980 (2009).
71. M. Wojtera, T. Sobow, I. Kłoszewska, et al., “Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer’s disease: morphometric study and review of the literature,” Folia Neuropathol., 50, No. 1, 74–84 (2012).
72. M. Yamada, K. Ohsawa, Y. Imai, et al., “x-Ray structure of the microglia/ macrophage-specific protein Iba1 from human and mouse demonstrate novel molecular conformation change induced by calcium binding,” J. Mol. Biol., 364, 449–457 (2006).
73. M.-H. Yi, E. Zhang, J. W. Kang, et al., “Expression of CD200 in alternative activation of microglia following an excitotoxic lesion in the mouse hippocampus,” Brain Res., 1481, 90–96 (2012).